Published in Int J Endocrinol on November 04, 2013
Association of ACTN3 polymorphisms with BMD, and physical fitness of elderly women. J Phys Ther Sci (2016) 0.75
Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 16.98
Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 7.87
Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab (2001) 2.08
Genetics of leptin and obesity: a HuGE review. Am J Epidemiol (2005) 1.80
Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab (1998) 1.62
Leptin and the sympathetic connection of fat to bone. Osteoporos Int (2007) 1.61
Association analysis of the Gln223Arg polymorphism in the human leptin receptor gene, and traits related to obesity in Mexican adolescents. J Hum Hypertens (2005) 1.60
Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab (1997) 1.50
Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab (2000) 1.39
A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet (2001) 1.34
Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) (2001) 1.30
Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol (2004) 1.28
The height-, weight-, and BMI-for-age of Polish school-aged children and adolescents relative to international and local growth references. BMC Public Health (2010) 1.23
Obesity in patients with acute lymphoblastic leukemia in childhood. Ital J Pediatr (2012) 1.09
Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol (1998) 1.00
Late effects of childhood ALL treatment on body mass index and serum leptin levels. J Pediatr Endocrinol Metab (2010) 0.98
Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia. J Exp Clin Cancer Res (2011) 0.96
Functional consequences of the human leptin receptor (LEPR) Q223R transversion. Obesity (Silver Spring) (2008) 0.96
Hypothalamic regulation of bone. J Mol Endocrinol (2010) 0.95
Estrogen receptor alpha gene polymorphisms Pvu II and Xba I influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men. Eur J Endocrinol (2002) 0.94
No association of LEPR Gln223Arg polymorphism with leptin, obesity or metabolic disturbances in children. Eur J Med Res (2009) 0.90
Leptin levels and leptin receptor polymorphism frequency in healthy populations. Infect Agent Cancer (2009) 0.89
Leptin receptor gene Gln223Arg polymorphism is not associated with obesity and metabolic syndrome in Turkish children. Turk J Pediatr (2012) 0.84
Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: a prospective study. Eur J Endocrinol (2000) 0.84
Bone mass in prepubertal boys is associated with a Gln223Arg amino acid substitution in the leptin receptor. J Clin Endocrinol Metab (2007) 0.84
Association of leptin receptor polymorphisms Lys109Arg and Gln223Arg with serum leptin profile and bone mineral density in Korean women. Am J Obstet Gynecol (2008) 0.83
The Gln223Arg polymorphism of the leptin receptor gene and peripheral blood/bone marrow leptin level in leukemic children. J Physiol Pharmacol (2006) 0.82
Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children. Rocz Akad Med Bialymst (2005) 0.81
Are serum leptin and the Gln223Arg polymorphism of the leptin receptor determinants of bone homeostasis in elderly men? Eur J Endocrinol (2006) 0.79
[Leptin receptor polymorphism--the evaluation of the hetero- and homozygote frequencies in population of children suffering from acute lymphoblastic leukemia (ALL) and healthy children]. Pol Merkur Lekarski (2011) 0.77
Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol (2010) 1.45
Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer. Cancer Immunol Immunother (2004) 1.41
Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene. Pediatr Blood Cancer (2009) 1.38
Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol (2013) 1.25
Patients' perceptions of GP non-verbal communication: a qualitative study. Br J Gen Pract (2010) 1.07
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92
[Treatment results of children with neuroblastoma: report of Polish Pediatric Solid Tumor Group]. Przegl Lek (2010) 0.92
Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol (2007) 0.89
A lineage switch from AML to ALL with persistent translocation t(4;11) in congenital leukemia. Med Pediatr Oncol (2003) 0.89
The patient's view of the acceptability of the primary care in Poland. Int J Qual Health Care (2008) 0.88
Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. J Cancer Res Clin Oncol (2007) 0.87
Involvement of family nurses in home visits during an 8-year period encompassing primary healthcare reforms in Poland. Health Soc Care Community (2008) 0.85
[Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences]. Med Wieku Rozwoj (2011) 0.81
Development of treatment and clinical results in childhood acute myeloid leukemia in Poland. Memo (2012) 0.81
Cerebrospinal fluid oxidative stress during chemotherapy of acute lymphoblastic leukemia in children. Pediatr Hematol Oncol (2010) 0.81
Little evidence of low bone mass in acute lymphoblastic leukemia survivors. J Clin Densitom (2011) 0.80
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions. Pediatr Hematol Oncol (2006) 0.80
Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis. Pediatr Nephrol (2013) 0.80
Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL. Leuk Res (2011) 0.79
Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study. Anticancer Res (2009) 0.79
[The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group]. Przegl Lek (2006) 0.79
[Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia]. Pol Merkur Lekarski (2007) 0.79
Monocytes in children with leukemias and lymphomas -- down-regulation of HLA and costimulatory molecules. Acta Biochim Pol (2004) 0.79
Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis. Mediators Inflamm (2013) 0.79
[Genotyping and minimal residual disease study in children with acute myeloid leukemia: preliminary results]. Przegl Lek (2010) 0.78
Comparison of phalangeal ultrasound and dual energy X-ray absorptiometry in healthy male and female adolescents. Ultrasound Med Biol (2005) 0.78
A need to establish normative data for plasma oxalates. Am J Kidney Dis (2008) 0.78
Influence of Iron Overload on Immunosuppressive Therapy in Children with Severe Aplastic Anemia. Adv Exp Med Biol (2015) 0.78
Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol (2008) 0.78
Body composition and bone mass in survivors of childhood cancer. Pediatr Blood Cancer (2007) 0.78
[Bone mineral density in children before and after completion of cancer treatment]. Pol Merkur Lekarski (2004) 0.77
[Ovarian malignant tumours. Efficacy of germ cell and sex cord tumour treatment protocol in Poland]. Med Wieku Rozwoj (2007) 0.77
Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 0.77
[Results of immunosuppressive therapy in children with severe aplastic anaemia. Report by the Polish Paediatric Leukaemia and Lymphoma Study Group]. Med Wieku Rozwoj (2007) 0.77
[T-lymphocyte and monocyte activation in the course of infection in children with neoplastic disease]. Med Wieku Rozwoj (2002) 0.77
Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children. Arch Immunol Ther Exp (Warsz) (2005) 0.77
[Leptin receptor polymorphism--the evaluation of the hetero- and homozygote frequencies in population of children suffering from acute lymphoblastic leukemia (ALL) and healthy children]. Pol Merkur Lekarski (2011) 0.77
Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease? Pediatr Hematol Oncol (2009) 0.76
[Regulatory T cells in children with acute lymphoblastic leukaemia]. Med Wieku Rozwoj (2009) 0.76
Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation. Ann Hematol (2007) 0.76
[Experimental and selected clinical aspects of active immunotherapy in leukemia]. Postepy Hig Med Dosw (Online) (2006) 0.76
Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes. Med Pediatr Oncol (2002) 0.75
Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75
Low milk consumption in childhood and fragility fractures. Comment on an article by Monti et al. Ann Nutr Metab (2008) 0.75
Serum matrix metalloproteinase-9 levels and severity of symptoms in boys with attention deficit hyperactivity disorder ADHD/hyperkinetic disorder HKD. Eur Child Adolesc Psychiatry (2014) 0.75
New insight into the role of patients during medical appointments: a synthesis of three qualitative studies. Patient (2014) 0.75
Some remarks on self-reported and measured height and weight in adolescents. J Adolesc Health (2006) 0.75
CD40L and IL-4 stimulation of acute lymphoblastic leukemia cells results in upregulation of mRNA level of FLICE--an important component of apoptosis. Folia Histochem Cytobiol (2007) 0.75
[Plasma proteasome 20S activity in children treated for acute lymphoblastic leukaemia]. Med Wieku Rozwoj (2007) 0.75
[Malignant germ cell tumours. Multicenter prospective trial in Polish Pediatric Group for Solid Tumours (years 1998-2000)]. Przegl Lek (2004) 0.75
["Magic bullets"--monoclonal antibodies in acute leukemia and non-Hodgkin's lymphoma treatment]. Postepy Hig Med Dosw (2002) 0.75
[Immunophenotype of lymphoblastic leukaemia in children in relation to clinical symptoms and laboratory tests, preceding its diagnosis]. Med Wieku Rozwoj (2005) 0.75
Level of tau protein in children treated for acute lymphoblastic leukemia. Pediatr Neurol (2006) 0.75
[Osteonecrosis--underestimated problem of children oncology]. Pol Merkur Lekarski (2006) 0.75
Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol. Acta Haematol (2004) 0.75
[Costimulatory and activation molecules of lymphocytes T in acute lymphoblastic leukemia in children]. Przegl Lek (2004) 0.75
[History of the Child Oncology Clinic at Medical University, Bialystok, Poland]. Med Wieku Rozwoj (2008) 0.75
[Analysis of risk factor treatment failures in therapeutic programme for malignant germ cell tumours in children. Multicentre prospective study of Polish Pediatric Group for Solid Tumours 1998--2006]. Med Wieku Rozwoj (2008) 0.75
CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. Acta Biochim Pol (2006) 0.75
[Immunotherapy in aplastic anaemia as a cause of reactivation of hepatitis B virus-immunologic aspects]. Wiad Lek (2005) 0.75
Primitive neuroectodermal tumor in 3-year-old boy with Beckwith-Wiedemann syndrome. Pediatr Blood Cancer (2007) 0.75
[Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland]. Med Wieku Rozwoj (2007) 0.75
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications]. Przegl Lek (2004) 0.75
[Biochemical markers of bone formation activity in children with neoplasms]. Wiad Lek (2005) 0.75
[Analysis of an abnormal coagulation profile in children qualified for adenoidectomy/tonsilectomy]. Otolaryngol Pol (2007) 0.75
[Influence of age on treatment results in children and adolescents with Hodgkin's disease]. Przegl Lek (2004) 0.75
Lower expression of mRNA for interferon-gamma in T helper cells of children with newly diagnosed lymphomas. Folia Histochem Cytobiol (2005) 0.75
Respiratory and systemic infections in children with severe aplastic anemia on immunosuppressive therapy. Adv Exp Med Biol (2013) 0.75
[Vertebral compression fractures--the first manifestations of acute lymphoblastic leukemia of childhood]. Med Wieku Rozwoj (2005) 0.75
[Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)]. Przegl Lek (2004) 0.75
[Genitourinary soft tissue sarcomas located outside bladder and prostate in children treated according to the CWS-96 protocol--report from the Polish Paediatric Solid Tumours Study Group]. Med Wieku Rozwoj (2006) 0.75
[Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections]. Wiad Lek (2004) 0.75
[Th1/Th2 balance in acute lymphoblastic leukemia in children]. Przegl Lek (2004) 0.75
[Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children]. Pol Merkur Lekarski (2004) 0.75
[Relationship between body mass index and leptin levels in children treated for acute lymphoblastic leukemia during and after maintenance therapy]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw (2006) 0.75
[Allergy and cancer]. Pol Arch Med Wewn (2003) 0.75
[Myeloid-derived suppressor cells - the new mechanism of immunosuppression in cancer]. Postepy Hig Med Dosw (Online) (2008) 0.75
[Rare tumours--are they really rare in the Polish children population?]. Przegl Lek (2004) 0.75
[Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood]. Med Wieku Rozwoj (2005) 0.75
Immunologic monitoring of maintenance therapy for acute lymphoblastic leukaemia in children-preliminary report. Pediatr Blood Cancer (2004) 0.75
[Mechanisms of immunosuppression in leukemia]. Postepy Hig Med Dosw (Online) (2005) 0.75
[Leptin, body composition and bone mineralization in children after treatment for Wilms tumor]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw (2004) 0.75
Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia. Anticancer Res (2007) 0.75